ISRCTN28479470已完成3 期
A prospective, multicenter, open-label study to evaluate the safety and efficacy of DE-AT0217 versus standard of care (e.g. calcipotriol) in adult patients diagnosed with mild to moderatepsoriasis
Devintec SAG0 个研究点目标入组 42 人开始时间: 2021年12月16日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Adult subjects 18 years or older
- •2. Subjects willing to sign the informed consent
- •3. Subjects previously diagnosed with mild to moderate plaque psoriasis
- •4. Subjects willing and able to comply with all clinic visits and study-related procedures
排除标准
- •1. Use of systemic and topical anti psoriatic therapy on the areas within 2 weeks prior to the beginning of the study
- •2. Concomitant use of systemic anti psoriatic therapy (e.g. methotrexate, biologics, phototherapy)
- •3. Concomitant use of topical corticotherapy
- •3. Any dermatological disease that might interfere psoriasis clinical evaluation or bring the subject in danger, or have other serious dermatological disease other than psoriasis
- •4. Pregnant or breast-feeding women or women planning to become pregnant or breastfeed during the study.
- •5. Hypersensitivity or allergy to any of the IMP ingredients
研究者
相似试验
招募中
3 期
A Study to Learn How Gadoquatrane Moves Into, Through, and Out of the Body and How Safe it is in Children (From Birth to <18 Years), Who Will Undergo a Contrast Enhanced MRI (Quanti Pediatric)JPRN-jRCT2011230024Myoishi Masafumi100
尚未招募
4 期
Comparison of personalised coaching program with standard of care in Type 2 diabetes managementCTRI/2024/05/068043Ragus Healthcare Private Limited
进行中（未招募）
不适用
An non-blinded, mulicenter study to investigate the mechanisms which are involved in the interaction of red blood cells with the study drug IgPro10 in patients with chronic immune thrombocytopenic purpura (ITP) who have shown signs of hemolysis (a breakdown or destruction of red blood cells).Chronic immune thrombocytopenic purpura (ITP)MedDRA version: 16.0Level: PTClassification code 10021245Term: Idiopathic thrombocytopenic purpuraSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2011-000263-27-BGCSL Behring GmbH150
进行中（未招募）
不适用
An non-blinded, mulicenter study to investigate the mechanisms which are involved in the interaction of red blood cells with the study drug IgPro10 in patients with chronic immune thrombocytopenic purpura (ITP) who have shown signs of hemolysis (a breakdown or destruction of red blood cells).Chronic immune thrombocytopenic purpura (ITP)MedDRA version: 15.0Level: PTClassification code 10021245Term: Idiopathic thrombocytopenic purpuraSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2011-000263-27-PLCSL Behring LLC150
进行中（未招募）
1 期
An open label, prospective, multicenter study investigating clinical efficacy, safety, and pharmacokinetic properties of the human normal immunoglobulin for intravenous administration BT595 as replacement therapy in patients with primary immunodeficiency disease (PID)Replacement therapy in patients with primary immunodeficiency disease (PID)MedDRA version: 20.0Level: PTClassification code 10064859Term: Primary immunodeficiency syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2015-003652-52-DEBiotest AG70